Orchard Therapeutics Plc ADR (ORTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2017 | 12-2016 | 12-2006 | |
| Cash Flows From Operating Activities | |||
| Net Income | -39,744 | -19,085 | N/A |
| Depreciation Amortization | 302 | 6 | N/A |
| Accounts payable and accrued liabilities | 1,930 | 666 | N/A |
| Other Working Capital | 2,810 | 1,509 | N/A |
| Other Operating Activity | 2,215 | 2,338 | 0 |
| Operating Cash Flow | $-32,487 | $-14,566 | $N/A |
| Cash Flows From Investing Activities | |||
| PPE Investments | -1,559 | -190 | N/A |
| Investing Cash Flow | $-1,559 | $-190 | $N/A |
| Cash Flows From Financing Activities | |||
| Other Financing Activity | 115,696 | 18,034 | 0 |
| Financing Cash Flow | $115,696 | $18,034 | $N/A |
| Exchange Rate Effect | 4,709 | -751 | N/A |
| Beginning Cash Position | 3,497 | 970 | N/A |
| End Cash Position | 89,856 | 3,497 | N/A |
| Net Cash Flow | $86,359 | $2,527 | $N/A |
| Free Cash Flow | |||
| Operating Cash Flow | -32,487 | -14,566 | N/A |
| Capital Expenditure | -1,559 | -190 | N/A |
| Free Cash Flow | -34,046 | -14,756 | 0 |